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Despite increased operator experience and skill and 
improved technology of balloons and x-ray equip- 
ment, the incidence of abrupt occlusion has not de- 
creased dramatically and is reported to be between 
4.4% and 8.3% l-7 (Table I). The lack of decreased 
incidence of acute occlusion is the result of the pro- 
portional increase of patients who undergo dilation of 
complex lesions and of acute ischemic syndromes 
that are associated with a higher likelihood of acute 
occlusion.l, 4* 8 Abrupt coronary occlusion is a highly 
unwanted, often unpredictable event associated with 
major complications including death and myocardial 
infarction; it is the main reason for the requirement 
for immediate surgical back-up (Table I). This arti- 
cle reviews the incidence, predictors, and current 
management of abrupt coronary occlusion during 
coronary intervention. 
INCIDENCE AND PREDICTORS 
Morphologic causes of acute coronary occlusion. The 
mechanisms of abrupt coronary artery occlusion in- 
clude a combination of mechanical obstruction caused 
by (sub)occlusive dissection, subintimal hemorrhage 
under the plaque, thrombus formation, vasoconstric- 
tion, and elastic recoiLg-12 Invariably, recoil occurs 
after balloon angioplasty, accounting for approxi- 
mately 40% to 50% of immediate lumen 10ss.l~ The 
establishment of the other causes of acute coronary 
occlusion is being hampered by the insensitivity of 
angiography to reliably identify the main mechanism 
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of occlusion. Generally, one distinguishes between 
either thrombus or occlusive dissection, but often the 
mechanism is indeterminate. Thrombus formation 
was thought to be the predominant mechanism in 
19 % to 33 % of patients, dissection in 26 % , and the 
combination in 7 % , whereas in 42 % it was not pos- 
sible to establish the underlying cause.5v6 These 
findings clearly reflect the inability of angiography to 
reliably detect intracoronary abnormalities. Newer 
intracoronary imaging techniques such as intracoro- 
nary ultrasound imaging and angioscopy may be 
useful in establishing the mechanisms and helpful in 
guiding optimal management. 
Incidence of abrupt occlusion. Abrupt coronary oc- 
clusion was defined as clinical or electrocardiographic 
evidence of myocardial ischemia and a complete 
(Thrombolysis In Myocardial Infarction [TIMI grade 
01) or critical reduction (TIM1 grades 1 or 2) in cor- 
onary blood flow of a previously patent (TIM1 grades 
2 or 3) coronary vessel segment occurring during or 
after coronary intervention within the period of hos- 
pitalization. Abrupt coronary occlusion of a previ- 
ously totally occluded artery was defined as reclosure 
(TIM1 grades 0 or 1) after establishment of TIM1 
grade 3 flow during initial successful intervention; 
this reclosure may be associated with ischemia. The 
reported incidence of abrupt coronary occlusion dur- 
ing and after coronary intervention ranges from 4.4 % 
to 8.3%) with an average of 5.7 % l-7 (Table I). 
Predictors of abrupt coronary occlusion. For optimal 
clinical decision-making and patient counseling, it 
would be desirable if one could identify preproce- 
dural and procedural high-risk procedures. Several 
predictors for acute coronary occlusion have been 
identified (Table II), but unfortunately they gen- 
erally have a low positive or negative predictive 
value.3-5,8> 13-16 However, the make-up of a risk pro- 
file for each patient is often helpful and allows a crude 
estimation of the potential risk, such that in case of 
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Table 1. Incidence and major complications associated with (sub)acute occlusion during balloon angioplasty 
Early experience 
NHLBI-PTCA 
Registry I1 
Beth Israel2 
Emory3 
Late experience 
NHLBI-PTCA 
Registry II4 
Thorax Center5 
Ann Arbor6 
San Francisco 
Heart Institute7 
Totals (average) 
Year 
‘83 
‘88 
‘88 
‘90 
‘91 
‘92 
‘92 
Study 
period 
‘77-‘81 
‘81-‘86 
‘82-‘86 
‘85-‘86 
‘86-‘88 
‘88-‘90 
‘90-‘91 
No. of 
patients 
1,500 
1,160 
4,772 
1,801 
1,423 
1,319 
553 
11,028 
Incidence of 
(sub)acute 
occlusion 
No. (5%) 
112 (7.5)* 
54 (4.7) 
210 (4.4) 
122 (6.8) 
104 (7.3) 
109 (8.3) 
27 (4.9) 
626 (5.7) 
Death 
No. (%I 
8 (7.2) 
l(1.9) 
4 (2.9H 
6 (4.9) 
6 (6.0) 
9 (8.3) 
0 (0) 
26 (4.7) 
Major complications 
AMI Emergency CABG 
No. (70) No. (5%) 
41 (37) 86 (77) 
19 (35) 18 (33) 
56 (Wt 78 (55)t 
49 (40) 49 (40) 
37 (36) 30 (31) 
22 (20) 25 (23) 
9 (33) 11 (41) 
192 (35) 211 (38) 
AMI, Acute myocardial infarction; CAEG, coronary artery bypass grafting; NHLBI, National Heart, Lung, and Blood Institute; PTCA, percutaneous trans- 
luminal coronary angioplasty. 
*Acute occlusion + major dissection causing complications. 
@ubgroup analysis of 140 patients with suitable review angiograms. 
Table II. Predictors of acute coronary occlusion 
Preprocedural 
Clinical predictors: 
Female sex3 
Unstable angina42 5, l4 
Diabetes mellitus13 
Extreme agel 
Inadequate platelet therapy16 
Lesion predictors: 
Intracoronary thrombus3, 4, I3 
Severe narrowin& 
Long lesion33 I3 
Complex lesion5 
Lesion at branch point3 
Lesion at bend point 
(>45”)3,13,14 
ACCIAHA lesion score 
Bz,C’3, I4 
Postprocedura~ 
Dissection39 4, l4 
Remaining stenosis gradient 
> 20 mm Hg3 
Angiographic predictors: 
Multivessel 5, 8 
Multilesion3* 4, 8 
Collateral flow from 
the target vesse13v 4 
ACC, American College of Cardiology; AHA, American Heart Association. 
the absence of any risk factor the probability of acute 
occlusion is very low (2 % ), whereas the presence of 
one or more risk factors clearly increases the proba- 
bility of acute coronary occlusion. In case of the 
presence of three risk factors,5 this may add up to a 
25 % probability.5 
Obviously, identification of risk factors predictive 
of procedural death is important. It appears that 
procedural death is closely related to the presence of 
a large amount of myocardium at risk, although the 
extent of preexisting nonviable myocardium should 
also be considered. Predictors of death are left main 
coronary artery disease, collaterals originating from 
the attempted dilated vessel, severely compromised 
left ventricular function, and female sex.8j l7 Ade- 
quate prediction of the likelihood of acute occlusion 
has important consequences for the surgical stand- 
by. Patients with excessive risk for balloon angio- 
plasty should be referred for elective bypass surgery. 
High-risk patients require active surgical standby, 
whereas medium and low-risk patients require only 
passive surgical standby. 
MANAGEMENT 
The recently proposed 1988 American College of In-hospital outcome of acute coronary occlusion. In 
Cardiology/American Heart Association (AC C/AHA) the very early experience of percutaneous translumi- 
Task Force classification scheme that categorizes le- nal coronary angioplasty (PTCA), acute coronary 
sions into types A, B, and C was developed to classify occlusion complicating PTCA was traditionally 
patients with high, medium, and low risk. Myler et treated with an emergency coronary artery bypass 
a1.7 report the short-term results in 553 consecutive 
patients classified according to this scheme. Angio- 
plasty success was achieved in 99 % of type A, in 92 % 
of type B, and in 90% of type C lesions. Untoward 
events occurred in 1.2 % of type A, in 1.9 % of type B, 
and in 2 % of type C lesions. These results are clearly 
outside the range of the classification and seriously 
bring into question the value of the classification. An 
updated classification system needs to be developed 
that better fits the results obtained with current bal- 
loon technology. 
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Table Ill. Outcome after initial successful redilation of acute occlusion 
Major in-hospital complications 
after successful redilation 
Successful 
No. of patients with redilation Death MI Em CABG 
attempted redilation % (No.) % 0Jo.i % (No.) % (No.) 
Beth Israel’ 43 5li22) 0 (0) 14 (3) 0 (0) 
NHLBI-PTCA II4 122 49 (60) 5 (3) 27 (16) 10 (6) 
Thorax Center5 95 35 (33) 3 (1) 3 (1) 3 (1) 
Totals (average) 260 44 (115) 3.5 (4) 17 (20) 6 (7) 
Em, Emergency; MI, myocardial infarction; other abbreviations as in Table I. 
Table IV. Outcome of treatment of abrupt occlusion with intracoronary or intravenous thrombolytics and redilatation 
Study 
No. of 
patients 
Clinical 
Success 
No. (%) 
Failure with major 
complications 
Failure without 
Death MI Em CABG major complications Thrombolytic 
(No.) (No.) (No.) (No.) treatment 
Gulbazo* 27 
Schieman21t 48 
de Feyter5* 34 
Vernaz2* 23 
Vaitkusz3t 27 
Totals (average) 159 
13 (48) 0 14 2 0 TPA 
43 (90) 0 0 1 5 Urokinase 
18 (53) 2 13 5 0 Streptokinase 
15 (65) 1 5 3 0 Urokinase 
14 (52) 0 8 4 0 Urokinase 
103 (65) 3 (1.9) 40 (25) 15 (9.5) 5 (3.2) 
TPA, Tissue plasminogen activator; other abbreviations as in Tables I and III. 
*Abrupt occlusion during PTCA of patients with stable and unstable angina 
?A11 patients had PTCA for acute ischemic syndromes. 
0peration.l However, as experience accumulated, it 
became established practice, after first ruling out the 
possibility of acute occlusive coronary spasm with 
intracoronary nitroglycerin, to perform immediate 
redilation.18t lg Successful initial redilation can be 
achieved in an average of 44 % of patients (Table III). 
Although the reopening is sustained in the majority 
of patients, in a few patients reocclusion with death, 
myocardial infarction, and the need for emergency 
surgery occurs (Table III). When initial redilation 
was unsuccessful and thrombus formation appeared, 
adjunctive thrombolytic treatment, in combination 
with repeated dilation, was given. The outcome of 
this combined approach is displayed in Table IV; the 
average success rate was 65 % .51 16-23 Failure of this 
combined treatment cannot totally be attributed to 
failure of thrombolytic therapy, but should also be 
ascribed to the difficulty in differentiating between 
dissection and thrombus using angiography. New in- 
tracoronary imaging techniques such as intracoro- 
nary angioscopy should be able to better distinguish 
between these mechanisms and should facilitate the 
management of these patients. 
Emergency surgery after failed PTCA has been 
shown to be associated with a high mortality (aver- 
Table V. In-hospital results of emergency bypass surgery 
after failed balloon angioplasty* 
Total Emergency 
group CABG 
No. No. (%j 
Cowleyz4 3,079 202 (7) 
Goldingz5 1,831 81 (4.5) 
Kille@ 3,000 115 (4) 
Reu127 518 70 (13.5) 
Talleyzs 7,246 430 (6.0) 
Greenezs 1,214 53 (4.4) 
Totals (average) 16,888 951 (5.7) 
Q waue 
MI Mortality 
No. (%) No. (%) 
52 (26) 13 (6.5) 
37 (46) 2 (2.5) 
50 (44) 13 (11) 
8 (11.4) 4 (5.7) 
91 (21) 6 (1.4) 
27 (51) 2 (4.0) 
265 (28) 40 (4.2) 
Abbreviations as in Tables I and III. 
*Selected were studies that included patients with more than 500 angio- 
plasty procedures. 
age 4.2 % ), and the progression to a myocardial 
infarction can not be prevented in 28 % of patients on 
average (Table V).24-2g The main feature that corre- 
lated best with perioperative death and myocardial 
infarction after acute surgery for complicated angio- 
plasty appeared to be ongoing ischemia and hemo- 
dynamic instability. 3o The overall outcome of the 
management of acute occlusion using either redila- 
tion or a combination of thrombolytics and, in case of 
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Table VI. Overall management outcome of acute occlusion using a combination of redilation, thrombolysis, and 
emergency surgery 
Management In-hospital outcome 
Failure, with 
No. of complications 
patients Initial Failure, 
with acute Conservative re-PTCA Thrombolytics Em CABG Successf no complications MI Death 
occlusion No. (%) No. (%) No. (%) No. (%) No. (%) No. (%) No. B-0) No. (70) 
Beth Israel2 54 14 (26) 40 (74) 0 (0) 18 (33) 31 (57) 8 (15) 19 (35) 1 (2.0) 
NHLBI-PTCA II4 122 20 (16) 103 (84) 0 (0) 43 (35) 60 (49) 9 (7) 48 (39) 6 (5.0) 
Thorax Center5 104 5 (5) 95 (91) 34 (33) 31 (30) 56 (54) 4 (4) 37 (36) 6 (6.0) 
Ann Arbor6 109 0 (0) 98* (90) 42 (39) 25 (23) 61 (56) 17 (16) 22 (20) 9 (8.0) 
Totals (average) 389 39 (10) 336 (87) 76 (20) 117 (30) 208 (53) 38 (10) 126 (33) 22 (5.7) 
Abbreviations as in Tables I and III. 
*In 11 of 109 patients other techniques (stent nine; atherectomy nine) were employed. 
tSuccess was defined as a successful reopened vessel or successful CABG without the occurrence of death or myocardial infarction. 
Table VII. In-hospital events following stent implantation for threatened or acute occlusion after balloon angioplasty 
Study No. of Successful 
Year period patients stent delivery 
Complications Subsequent occlusion 
Death AMI Em CABG Incidence Time interval 
Wallstent 
Sigwart et a1.35 ‘88 ‘86-‘88 11 100% 1(9%) 0 0 1(9%) 
de Feyter et a1.36 ‘90 ‘89-‘90 15 100% l(6.690) 2 (13.3%) 9 (60%)* 3 (20%) 
Goy et a1.“7 ‘92 NR 17 100% 0 1(5.8%) 0 1 (5.8%) 
Palmaz-Schatz stent 
Haude et a1.38 ‘91 NR 15 100% 0 0 1(6.7%) 1(6.7%) 
Herrmann et a1.3g+ ‘92 ‘88-‘91 56 98% 2 (3.6%) 11 (20%) 7 (13%) 9 (16%) 
Reifart et a1.40 ‘92 ‘90-‘91 64 95% 4 (6%) 2 (3%) 7 (11%) 20 (31%) 
Gianturco-Roubin stent 
Roubin et a1.41 ‘92 ‘89-‘91 115 96% 2 (1.7%) 8 (6.7% )$ 5 (4.2%) 9 (7.6%) 
Strecker stent 
Reifart et al.4o ‘92 ‘go-‘91 48 97% 5 (10%) 1(2%) 3 (6%) 10 (21%) 
Wiktor stent 
Vrolix et a1.42 ‘92 ‘91 119 95% 4 (3%) NR 7 (6%) 14 (12%) 
Totals (average) 460 97% 19 (4.1%) 25 (10.6%) 39 (8.4%) 68 (14.7%) 
NR, Not reported; other abbreviations as in Tables I and III. 
*Includes the 8 patients in whom the stent was used as a bridge to surgery. 
tEvents within 30 days after stent implantation are reported. 
$If patients in whom the stent was implanted because of evolving AMI are excluded, value is 4 % . 
NR 
Day O-7 
Day 0 
Day 0 
Daysl-10 
DaysO- 
Days 1-5 
DaysO- 
NR 
failure, emergency surgery, is presented in Table VI. 
The incidence of death after acute occlusion was an 
average 5.7 % , and a myocardial infarction occurred 
in 33 % of the patients. The average success rate was 
53 % (success being defined as an open vessel or suc- 
cessful bypass surgery without the occurrence of 
death or myocardial infarction). 
Prolonged balloon inflations. Prolonged balloon in- 
flations may improve the immediate result after 
PTCA because a long inflation time may improve re- 
modeling of the atherosclerotic obstruction or may 
“tack-up” a coronary occlusive flap. It is important to 
note, however, that long-lasting inflations cannot al- 
ways be tolerated by the patient. Catheter reperfu- 
sion techniques have made it possible to perform long 
inflations while keeping the patient perfused, and 
they also allow initial ischemic, hemodynamic stabi- 
lization as a “bridge” to immediate surgery.31* 32 In 
selected patients, it was possible to obtain a satisfac- 
tory result with long-lasting inflations using the au- 
toperfusion catheter. 33, 34 It should be noted, how- 
ever, that it is not always possible to use autoperfu- 
sion catheters because vessels are small in caliber, 
tortuous, the lesions are angulated, or thrombus ap- 
pears to play a significant role. The rather low 
efficacy of the “standard” management of acute cor- 
onary occlusion including redilation (even with long- 
lasting inflations and a bigger balloon) thrombolytic 
treatment and emergency surgery has prompted the 
search for more effective treatment modalities. 
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Table VIII. Incidence and related acute major complications of short-term occlusion after use of new interventional 
techniques 
Major complications 
Short-term 
No. of occlusion Death AMI Em CABG 
Technique patients No. (%) No. (%J No. (%) No. f%j 
Popma43* DCA 934 43 (4.3) 2 (0.2) 17 (1.8) 25 (2.7) 
Lee44* Excimer laser 1893 123 (6.5) 9 (0.4) 54 (2.9) 63 (3.3) 
Aguirre45t Rotational 
Coronary ablation 907 NR 1 (0.1) 78 (8.6) 13 (1.5) 
DCA, Directional coronary atherectomy; other abbreviations as in Table I. 
*Data pooled from Holmes et al. [Abstract]. Circulation 1991;84(suppl II):II-362; Bitt1 et al. [Abstract]. Circulation 1990;82(suppl III):III-670; and European 
Study Group [Abstract]. Circulation 1991;84(suppl II):II-362. 
TData pooled from Stertzer et al. J Am Co11 Cardiol 1993;21:287-95; Bertrand et al. Am J Cardiol 1992:69:470-4; Teirstein et al. J Am Co11 Cardiol 
1991;18:1694-701; and Buchbinder et al. [Abstract]. J Am Co11 Cardiol 1991;17(suppl Ak31A. 
Bail-out stenting for treatment of refractory acute 
coronary occlusion. Acute symptomatic occlusion re- 
fractory to repeat dilatation with or without adjunc- 
tive pharmacologic treatment is one of the most 
troublesome situations one may encounter during 
coronary angioplasty. A technique capable of restor- 
ing and maintaining antegrade flow, stabilizing the 
clinical condition, and obviating the need for emer- 
gency bypass surgery would be most welcome. Intra- 
coronary stent implantation prevents vessel collapse 
and tacks back intimal and medial tears, sealing the 
thrombogenic subintimal space. Clinical experience 
with bail-out stent implantation was first reported by 
Sigwart et a1.35 In a very limited number of patients, 
the self-expanding Wallstent was implanted, which 
resulted in an immediate restoration of adequate 
coronary flow, with normalization of the electrocar- 
diogram (ECG) and relief of symptoms with no evi- 
dence of acute myocardial infarction. Since then, 
each of the current clinically available stents has 
been used for this purpose with encouraging results 
(Table VII). 35-42 A high implantation success rate is 
reported, which is remarkable when one takes into 
account the technical difficulties that may be en- 
countered in a bail-out situation. Disappearance of 
angiographic landmarks and spasm of the vessel seg- 
ment may make stent delivery and correct position- 
ing very laborious. Data from randomized studies 
proving the superiority of stenting over other tech- 
niques or devices are lacking. It appears that bail-out 
stenting reduces the need for emergency bypass sur- 
gery and decreases the incidence of acute myocardial 
infarction (Table VII). 35-42 The results compare very 
favorably with those after abrupt closure following 
angioplasty without the use of bail-out stenting. This 
has prompted the recommendation that intracoro- 
nary stents should be available in all centers for bail- 
out procedures. 
A not totally resolved issue remains whether one 
should use a bail-out stent in situations associated 
with intracoronary thrombus formation, such as in 
patients with unstable angina or thrombotic abrupt 
occlusions. A case can be made for implanting a stent 
in association with the administration of throm- 
bolytic treatment. It may be expected that the stent 
induces brisk coronary flow, whereas intense throm- 
bolytic treatment dissolves remaining clot and anti- 
coagulation prevents clot formation. Thrombolytic 
treatment has also been advocated if there is a high 
suspicion of clot formation within the stented area 
after bail-out stent implantation. The incidence of 
subacute stent thrombosis has been reported to vary 
between 9% and 18% (on average, 15%) following 
bail-out stent implantation. To avoid stent throm- 
bosis, an intensive and meticulous anticoagulation 
effort is necessary. This in turn exposes the patient 
to an increased risk of serious bleeding complications 
including intracranial bleeding in 0.5 % , gastrointes- 
tinal bleeding in 2.8%) and groin bleeding in 7.5%. 
Pseudoaneurysm at the puncture site occurs in 4.2 % 
of patients. 
There are no clear guidelines with respect to the 
decision to refer the patient for semielective bypass 
surgery after successful bail-out stent implantation. 
This decision should be based on a number of factors 
such as the clinical status of the patient after stent- 
ing (relief of angina, normalization of the ECG, or 
hemodynamic parameters), angiographic factors (ac- 
quired TIM1 flow, presence or absence of intracoro- 
nary thrombus, complete or incomplete covering of 
the dissection, residual stenosis, territory at risk, 
presence or absence of collaterals), procedural factors 
(number and size of stents used), and the indication 
for bail-out stent implantation (suboptimal result 
versus threatened or frank vessel closure). 
Acute coronary occlusion after new techniques. New 
interventional techniques such as directional atherec- 
tomy, the excimer laser, or rotational ablation have 
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Table IX. Various indications for not performing percuta- 
neous reintervention 
Expected problems in recrossing the lesion 
Tortuosity/calcification/angulation 
Unstable guiding catheter 
Expected unfavorable redilation outcome 
Diffuse disease 
Long, spiral dissection 
Small caliber vessel 
Severe angulation 
High risk of damage to left main (stem) 
Severe hemodynamic instability 
Additional significant (nondilatable) lesions 
been developed to overcome some of the limitations 
of conventional balloon angioplasty. Unfortunately, 
these new techniques, although having the potential 
to be more effective in lesions where the balloon is 
limited, are associated with specific complications, in 
addition to the invariable occurrence of acute coro- 
nary occlusion and its related sequelae (Table 
VIII).43-45 Directional rotational ablation is associ- 
ated with the no-flow phenomenon (up to 17 %) and 
the excimer laser is associated with coronary vessel 
perforation (3.0 % ). 46 In particular, bifurcation le- 
sions and discrete noncalcific lesions have been 
shown to be associated with a higher likelihood of 
perforation with the excimer laser. It appears that 
the occurrence of acute closure and its related major 
complications is similar to that in balloon angio- 
plasty, except for rotational coronary ablations, which 
appear to be associated with. a high myocardial 
infarction rate (8.6%), albeit the majority of these 
instances were non-Q wave infarctions (7.1%). 
Current management of acute coronq occlusion. 
Crucial to the management of acute coronary occlu- 
sion is the necessity to keep the ischemic period as 
short as possible. Valuable time should not be wasted 
by cumbersome attempts to recross the lesion or to 
repeat unsuccessful dilatations, or to use techniques 
unfamiliar in the bperator’s catheterization labora- 
tory. First, measures should be taken to relieve the 
pain and anxiety. One of the most important deci- 
sions one must make is whether the patient should be 
referred for emergency bypass surgery or whether a 
percutaneous technique should be selected (Fig. lj. 
Various indications for not attempting a renewed 
percutaneous technique are listed in’Table IX; these 
patients are referred for surgery. If one has opted for 
acute bypass surgery, measures should be taken to 
stabilize or eliminate xnyocardial ischemia before 
surgery.30 It has been shown that the results of sur- 
gery are better if the patients tie not ische&c.28 If 
ischemia can not be reversed, precious time must not 
Table X. Indications that preclude bail-out stent 
implantation 
Anatomy 
Very small vessels (<2.0 mm) 
Severe angulation point 
Severe tortuosity 
Very long dissection 
Very proximal LAD or CX dissection necessitating stent 
implantation in left main stem 
Thrombosis main component of acute occlusion 
Clinical situation 
Refractory unstable angina (Bramiwald class IIIB and IIIC) 
Acute myocardial infarction 
Contraindication for intensive anticoagulant or antiplatelet 
treatment 
LAD, Left anterior descending coronary artery: CX, circumflex coronary 
artery. 
be lost and the myocardium should be revascularized 
as soon as possible. If one has decided in favor of an 
attempt with a percutaneous technique such as is the 
case in the majority of patients, in particular if the 
guide wire is still across the lesion, one performs an 
immediate inflation (short or long-lasting) with the 
same or a bigger balloon or with the use of an auto- 
perfusion balloon. If this fails and occlusive dissec- 
tion appears the cause, one should now consider the 
implantation of a bail-out stent. Bail-out stent im- 
plantation is preferred above other new techniques 
(laser, directional coronary atherectomy [DCA]) be- 
cause of its more general acceptance, wider availabil- 
ity, and proven efficacy. Again, it is important not to 
waste valuable time. Prompt stent placement is 
associated with a low incidence of both myocardial 
infarction and the need for emergency bypass sur- 
gery.47 However, stent implantation is precluded in 
the various situations listed in Table X; in these sit- 
uations’ it is probably wiser to refer the patient for 
emergency bypass surgery or, if thrombus formation 
is thought to play an important role, one may first 
attempt to reopen the vessel with adjunctive throm- 
bolytic therapy. In hemodynamically unstable or 
life-threatening situations (left main artery occlusion 
or a very proximal, large left anterior descending ar- 
tery), insertion of an intraaortic balloon pump or, if 
available, a percutaneous cardiopulmonary support 
device, should stabilize the patient and permit either 
a definite “work-up” of the acute occlusion or serve 
as a bridge until emergency surgery. 
Conclusions. It is difficult to predict worse outcome 
during coronary intervention in an individual pa- 
tient. The recently proposed AHAIACC classifica- 
tion to predict success and complication rate appears 
outdated. A new updated classification should be de- 
vised, based on lesion-specification that will allow 
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Percutaneous technique(s) 
I 
Yds “Unstable” 
Failure 
Emergent bypass surgery 
Fig. 1. Triage approach to the patient with acute coronary occlusion. IABP, Intraaortic balloon pump; 
CPS, cardiopulmonary support. 
classification of patients into high-, medium-, and 
low-risk groups. Ultravascular ultrasound will pro- 
vide lesion-specific information that may either guide 
the use of specific devices or predict worse outcome. 
Newer techniques for specific lesions are expected to 
decrease acute complications. In case of acute occlu- 
sion, the use of angioscopy or intravascular ultra- 
sound imaging will provide a better explanation of 
the direct underlying cause of the acute occlusion. 
Differentiation between dissection and thrombosis, 
and better delineation of the depth and extent of a 
dissection will increase our strategies to manage 
acute occlusion. Recoil or frank dissection will more 
readily be treated by intracoronary stenting tech- 
niques and we will be able to prevent or reverse acute 
occlusion in a substantial number of patients. The 
availability of more potent antiplatelet aggregation 
drugs, or newer anticoagulant drugs such as specific 
antithrombins, may provide options that may help us 
more effectively treat or prevent the occurrence of 
acute coronary occlusion. However, taking into ac- 
count that the indications for coronary intervention 
are expected to expand, that these new cases will be 
associated with a higher likelihood of acute coronary 
occlusion, and that not all cases of acute occlusion can 
be reversed with percutaneous techniques, emer- 
gency surgery will still be needed. It is our opinion 
that a hospital with an interventional program should 
fulfil the following requirements: (1) guarantee the 
presence of operators familiar with long-lasting in- 
flation and autoperfusion catheter techniques and (2) 
provide immediate access to a surgical back-up facil- 
ity. In addition, such a facility should preferably have 
(1) operators skilled in bail-out stent techniques or 
(2) availability of an intraaortic balloon pump or 
percutaneous cardiopulmonary support device. 
SUMMARY 
Acute coronary occlusion occurs in 4.3 % to 8.3 % of 
patients during coronary angioplasty. Its occurrence 
is difficult to predict in an individual patient. At high 
risk are patients with unstable angina, intracoronary 
thrombus, extreme age, long complex lesions, and 
diffuse disease. “Standard” management including 
redilation (prolonged perfusion) thrombolytic treat- 
ment and emergency bypass surgery is only success- 
ful in approximately 50% of the patients and is as- 
sociated with a high mortality and myocardial in- 
farction rate of <6 % and 30%) respectively. Bail-out 
stent implantation appears to emerge as an effective 
alternative in suitable patients and might reduce 
mortality, the apparent progression to myocardial 
infarction, or might decrease the need for emergency 
bypass. New techniques including directional 
atherectomy, rotational ablation, or the excimer laser 
are associated with a similar frequency of acute 
occlusion. Immediate access to a surgical back-up fa- 
cility remains necessary to treat refractory acute oc- 
clusions. 
We thank Claudia Sprenger de Rover for expert manuscript 
preparation. 
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Thrombolytic therapy in infants and children 
Shyam Sunder Kothari, DM, Sudhir Varma, DM, and Harbans Singh Wasir, DM 
New Delhi, India 
Thrombolytic therapy has been extensively used in 
adults. Several recent reviews have summarized the 
pharmacologic and clinical aspects of various throm- 
bolytic agents. 1-3 This therapy is also being increas- 
ingly used in neonates, infants, and children to treat 
various cardiac and other disorders. However, there 
appears to be an insufficient appreciation of the in- 
dications, efficacy, and safety of these agents in the 
pediatric population. In this article we review the 
published literature on the use of thrombolytic ther- 
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apy in neonates, infants, and children, and other re- 
lated issues. A wider appreciation of the contempo- 
rary experience would help in optimizing the utiliza- 
tion of thrombolytic therapy in the pediatric 
population. Streptokinase (SK), urokinase (UK), 
and recombinant tissue plasminogen activator 
(rTPA) have been used to treat the disorders dis- 
cussed below. 
CLINICAL APPLICATIONS 
Arterial thrombosis after cardiac catheterization. Ar- 
terial thrombosis after retrograde arterial catheter- 
ization occurs in 0.8% to 3.4% of patients despite 
systemic heparinization. 4p 5 It is more common in pa- 
tients weighing less than 10 kg and in whom balloon 
dilatation procedures are done through the arterial 
route. Consequently, the incidence of this complica- 
tion seems to be rising. Surgical thrombectomies in 
young patients do not produce optimal result& and 
might extend the vascular injury. On the other hand, 
